Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

被引：0
|
作者：
Julia Stockmann
Inge M. W. Verberk
Nina Timmesfeld
Robin Denz
Brian Budde
Julia Lange-Leifhelm
Philip Scheltens
Wiesje M. van der Flier
Andreas Nabers
Charlotte E. Teunissen
Klaus Gerwert
机构：
[1] Ruhr-University Bochum,Competence Center for Biospectroscopy, Center for Protein Diagnostics (PRODI)
[2] Ruhr University Bochum,Department of Biophysics
[3] Faculty of Biology and Biotechnology,Neurochemistry Laboratory, Department of Clinical Chemistry
[4] Amsterdam Neuroscience,Alzheimer Center Amsterdam, Department of Neurology
[5] Vrije Universiteit Amsterdam,Ruhr University Bochum, Department of Medical Informatics
[6] Amsterdam Neuroscience,undefined
[7] Vrije Universiteit Amsterdam,undefined
[8] Biometry and Epidemiology,undefined
来源：
Alzheimer's Research & Therapy | / 12卷
关键词：
Alzheimer’s disease; Amyloid beta (Aβ); Blood plasma; Risk stratification; Structure biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Subjective Cognitive Decline and Biomarkers of Preclinical Alzheimer's Disease
    Shokouhi, Sepideh
    Albert, Kimberly
    CURRENT BEHAVIORAL NEUROSCIENCE REPORTS, 2019, 6 (04) : 219 - 226
  • [42] Subjective cognitive decline: preclinical manifestation of Alzheimer's disease
    Lin, Yan
    Shan, Pei-Yan
    Jiang, Wen-Jing
    Sheng, Can
    Ma, Lin
    NEUROLOGICAL SCIENCES, 2019, 40 (01) : 41 - 49
  • [43] Amyloid- as a biomarker for Alzheimer's disease: quantification methods in body fluids
    Galozzi, Sara
    Marcus, Katrin
    Barkovits, Katalin
    EXPERT REVIEW OF PROTEOMICS, 2015, 12 (04) : 343 - 354
  • [44] Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline
    Pascual-Lucas, Maria
    Allue, Jose Antonio
    Sarasa, Leticia
    Fandos, Noelia
    Castillo, Sergio
    Terencio, Jose
    Sarasa, Manuel
    Tartari, Juan Pablo
    Sanabria, Angela
    Tarraga, Lluis
    Ruiz, Agustin
    Marquie, Marta
    Seo, Sang Won
    Jang, Hyemin
    Boada, Merce
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [45] Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline
    María Pascual-Lucas
    José Antonio Allué
    Leticia Sarasa
    Noelia Fandos
    Sergio Castillo
    Jose Terencio
    Manuel Sarasa
    Juan Pablo Tartari
    Ángela Sanabria
    Lluís Tárraga
    Agustín Ruíz
    Marta Marquié
    Sang Won Seo
    Hyemin Jang
    Mercè Boada
    Alzheimer's Research & Therapy, 15
  • [46] Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
    João Pedro Ferrari-Souza
    Pâmela C. L. Ferreira
    Bruna Bellaver
    Cécile Tissot
    Yi-Ting Wang
    Douglas T. Leffa
    Wagner S. Brum
    Andréa L. Benedet
    Nicholas J. Ashton
    Marco Antônio De Bastiani
    Andréia Rocha
    Joseph Therriault
    Firoza Z. Lussier
    Mira Chamoun
    Stijn Servaes
    Gleb Bezgin
    Min Su Kang
    Jenna Stevenson
    Nesrine Rahmouni
    Vanessa Pallen
    Nina Margherita Poltronetti
    William E. Klunk
    Dana L. Tudorascu
    Ann D. Cohen
    Victor L. Villemagne
    Serge Gauthier
    Kaj Blennow
    Henrik Zetterberg
    Diogo O. Souza
    Thomas K. Karikari
    Eduardo R. Zimmer
    Pedro Rosa-Neto
    Tharick A. Pascoal
    Molecular Psychiatry, 2022, 27 : 4781 - 4789
  • [47] The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease
    Wang-Dietrich, Lei
    Funke, Susanne Aileen
    Kuehbach, Katja
    Wang, Kun
    Besmehn, Astrid
    Willbold, Sabine
    Cinar, Yeliz
    Bannach, Oliver
    Birkmann, Eva
    Willbold, Dieter
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (04) : 985 - 994
  • [48] Subjective cognitive decline: preclinical manifestation of Alzheimer’s disease
    Yan Lin
    Pei-Yan Shan
    Wen-Jing Jiang
    Can Sheng
    Lin Ma
    Neurological Sciences, 2019, 40 : 41 - 49
  • [49] Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
    Holtta, Mikko
    Hansson, Oskar
    Andreasson, Ulf
    Hertze, Joakim
    Minthon, Lennart
    Nagga, Katarina
    Andreasen, Niels
    Zetterberg, Henrik
    Blennow, Kaj
    PLOS ONE, 2013, 8 (06):
  • [50] Amyloid-β as a Blood Biomarker for Alzheimer's Disease: A Review of Recent Literature
    Wang, Xiaoni
    Sun, Yu
    Li, Taoran
    Cai, Yanning
    Han, Ying
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (03) : 819 - 832
12345